Investigating a Vaccine Against COVID-19

NCT04400838 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

10811

Enrollment

OTHER

Sponsor class

Conditions

Coronavirus

Interventions

BIOLOGICAL: ChAdOx1 nCoV-19 (Abs 260)
BIOLOGICAL: MenACWY vaccine
BIOLOGICAL: ChAdOx1 nCoV-19 (Abs 260) + 2.2x10^10vp (qPCR) boost
BIOLOGICAL: Two dose MenACWY vaccine
BIOLOGICAL: ChAdOx1 nCoV-19 (qPCR)
BIOLOGICAL: ChAdOx1 nCoV-19 0.5mL prime plus boost
BIOLOGICAL: Two dose MenACWY vaccine min. 4 weeks apart
BIOLOGICAL: Two dose ChAdOx1 nCoV-19/Covishield 0.5mL
BIOLOGICAL: Two dose ChAdOx1 nCoV-19/Covishield 0.25mL & 0.5mL

Sponsor

University of Oxford